Hexavalent chromium-induced alteration of proteomic landscape in human skin fibroblast cells

Journal of Proteome Research

Volumn 12, Issue 7, 2013, Pages 3511-3518

  Guo, Lei ^a   Xiao, Yongsheng ^a   Wang, Yinsheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cholesterol biosynthesis; hexavalent chromium; human skin fibroblast; mass spectrometry; quantitative proteomics; SILAC

Indexed keywords

CHOLESTEROL; CHROMIUM; CHROMIUM(VI); DICHROMATE POTASSIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SKIN FIBROBLAST;

CELLS, CULTURED; CHOLESTEROL; CHROMIUM; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LOVASTATIN; PROTEOME; SKIN;

EID: 84879957838     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400375p     Document Type: Article

References (36)

1. Shanker, A. K. Trace Elements as Contaminants and Nutrients; John Wiley & Sons, Inc.: New York, 2008; pp 523-553
2. WHO. Chromium (Environmental Health Criteria 61). International Programme on Chemical Safety Geneva, Switzerland; World Health Organization: Geneva, 1990.
3. ATSDR. Toxicological Profile for Chromium; U.S. Department of Health and Human Services: Atlanta, GA, 2012.
4. Ding, M.; Shi, X. Molecular mechanisms of Cr(VI)-induced carcinogenesis Mol. Cell. Biochem. 2002, 234-235, 293-300
5. Kerger, B. D.; Paustenbach, D. J.; Corbett, G. E.; Finley, B. L. Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water Toxicol. Appl. Pharmacol. 1996, 141, 145-58
6. ATSDR. Toxicological Profile for Chromium; U.S. Department of Health and Human Services: Atlanta, GA, 2000.
7. Dayan, A. D.; Paine, A. J. Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000 Hum. Exp. Toxicol. 2001, 20, 439-51
8. Wise, S. S.; Holmes, A. L.; Wise, J. P., Sr. Hexavalent chromium-induced DNA damage and repair mechanisms Rev. Environ. Health 2008, 23, 39-57
9. De Mattia, G.; Bravi, M. C.; Laurenti, O.; De Luca, O.; Palmeri, A.; Sabatucci, A.; Mendico, G.; Ghiselli, A. Impairment of cell and plasma redox state in subjects professionally exposed to chromium Am. J. Ind. Med. 2004, 46, 120-5
10. Ye, J.; Shi, X. Gene expression profile in response to chromium-induced cell stress in A549 cells Mol. Cell. Biochem. 2001, 222, 189-97
11. Izzotti, A.; Bagnasco, M.; Cartiglia, C.; Longobardi, M.; De Flora, S. Proteomic analysis as related to transcriptome data in the lung of chromium(VI)-treated rats Int. J. Oncol. 2004, 24, 1513-22
12. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics Nature 2003, 422, 198-207
13. Ong, S.-E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1, 376-86
14. Cox, J.; Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 2008, 26, 1367-72
15. Salomonis, N.; Hanspers, K.; Zambon, A.; Vranizan, K.; Lawlor, S.; Dahlquist, K.; Doniger, S.; Stuart, J.; Conklin, B.; Pico, A. GenMAPP 2: new features and resources for pathway analysis BMC Bioinformatics 2007, 8, 217
16. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCt) method Methods 2001, 25, 402-8
17. Osada, K.; Ravandi, A.; Kuksis, A. Rapid analysis of oxidized cholesterol derivatives by high-performance liquid chromatography combined with diode-array ultraviolet and evaporative laser light-scattering detection J. Am. Oil Chem. Soc. 1999, 76, 863-71
18. Dong, X.; Xiong, L.; Jiang, X.; Wang, Y. Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in jurkat-T cells induced by doxorubicin J. Proteome. Res. 2010, 9, 5943-51
19. Defesche, J. C. Low-density lipoprotein receptor-its structure, function, and mutations Semin. Vasc. Med. 2004, 4, 5-11
20. Brown, M. S.; Goldstein, J. L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 11041-8
21. Horton, J. D.; Goldstein, J. L.; Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J. Clin. Invest. 2002, 109, 1125-31
22. Waris, G.; Felmlee, D. J.; Negro, F.; Siddiqui, A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress J. Virol. 2007, 81, 8122-30
23. Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. Molecular Biology of the Cell, 4 th ed.; Garland Science: New York, 2002.
24. Herold, G.; Jungwirth, R.; Rogler, G.; Geerling, I.; Stange, E. F. Influence of cholesterol supply on cell growth and differentiation in cultured enterocytes (CaCo-2) Digestion 1995, 56, 57-66
25. Tete, S.; Nicoletti, M.; Saggini, A.; Maccauro, G.; Rosati, M.; Conti, F.; Cianchetti, E.; Tripodi, D.; Toniato, E.; Fulcheri, M.; Salini, V.; Caraffa, A.; Antinolfi, P.; Frydas, S.; Pandolfi, F.; Conti, P.; Potalivo, G.; Theoharides, T. C. Nutrition and cancer prevention Int. J. Immunopathol. Pharmacol. 2012, 25, 573-81
26. Wong, W. W.; Dimitroulakos, J.; Minden, M. D.; Penn, L. Z. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 2002, 16, 508-19
27. Venkatakrishnan, A. J.; Deupi, X.; Lebon, G.; Tate, C. G.; Schertler, G. F.; Babu, M. M. Molecular signatures of G-protein-coupled receptors Nature 2013, 494, 185-94
28. Lappano, R.; Maggiolini, M. G protein-coupled receptors: novel targets for drug discovery in cancer Nat. Rev. Drug Discovery 2011, 10, 47-60
29. Dorsam, R. T.; Gutkind, J. S. G-protein-coupled receptors and cancer Nat. Rev. Cancer 2007, 7, 79-94
30. Wang, B. J.; Sheu, H. M.; Guo, Y. L.; Lee, Y. H.; Lai, C. S.; Pan, M. H.; Wang, Y. J. Hexavalent chromium induced ROS formation, Akt, NF-kappaB, and MAPK activation, and TNF-alpha and IL-1alpha production in keratinocytes Toxicol. Lett. 2010, 198, 216-24
31. Bubici, C.; Papa, S.; Dean, K.; Franzoso, G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance Oncogene 2006, 25, 6731-48
32. Reuter, S.; Gupta, S. C.; Chaturvedi, M. M.; Aggarwal, B. B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 2010, 49, 1603-16
33. Meno, S. R.; Nelson, R.; Hintze, K. J.; Self, W. T. Exposure to monomethylarsonous acid (MMAIII) leads to altered selenoprotein synthesis in a primary human lung cell model Toxicol. Appl. Pharmacol. 2009, 239, 130-6
34. Srivastava, M.; Singh, S.; Self, W. T. Exposure to silver nanoparticles inhibits selenoprotein synthesis and the activity of thioredoxin reductase Environ. Health Perspect. 2012, 120, 56-61
35. Lu, J.; Holmgren, A. Selenoproteins J. Biol. Chem. 2009, 284, 723-7
36. Huang, Z.; Rose, A. H.; Hoffmann, P. R. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities Antioxid. Redox Signaling 2012, 16, 705-43